StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / immunitybio.com

ImmunityBio

ImmunityBio (immunitybio.com): 9 changes recorded in its website history since July 2019. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeImmunityBio Announces Exclusive U.S. Deal for Tokyo-Strain BCG
    AfterImmunityBio Announces First Patients in Europe Treated with ANKTIVA®+BCG

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagecurrent websiteHistorical capture not publicly availableLink to observation
  2. HeadlineBetween and
    BeforeFDA Approved Expanded Access of Cancer Bioshield™ to treat Solid Tumor Lymphopenia
    AfterImmunityBio Announces Exclusive U.S. Deal for Tokyo-Strain BCG

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  3. ComplianceBetween and

    Now states FDA APPROVED and FDA-APPROVED compliance on its homepage.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  4. HeadlineBetween and
    BeforeANKTIVA’s permanent J Code, J9028, is active for billing purposes effective Jan 1, 2025
    AfterFDA Approved Expanded Access of Cancer Bioshield™ to treat Solid Tumor Lymphopenia

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  5. HeadlineBetween and
    BeforeOutsmart Your Disease ®
    AfterANKTIVA’s permanent J Code, J9028, is active for billing purposes effective Jan 1, 2025

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  6. HeadlineBetween and
    BeforeResearching Ways to Prevent Cancer
    AfterOutsmart Your Disease ®

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  7. HeadlineBetween and
    BeforeFinding Better Treatments for Bladder Cancer
    AfterResearching Ways to Prevent Cancer

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  8. HeadlineBetween and
    BeforeOutsmart Your Disease ™
    AfterFinding Better Treatments for Bladder Cancer

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  9. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 19 July 2019

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

ImmunityBio, a privately held immunotherapy company with a broad portfolio of over 40 biological molecules spanning first-in-class next-generation cytokine antibodies (Nantibody), fusion proteins, mon

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. Seen November 2026 · 1 capture · latest observed messagingImmunityBio Announces First Patients in Europe Treated with ANKTIVA®+BCG

    We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
  2. Seen July 2026 · 1 captureImmunityBio Announces Exclusive U.S. Deal for Tokyo-Strain BCG

    We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.

    This wording observed 29 July 2026.

    archived page
  3. Seen July 2025 · 1 captureFDA Approved Expanded Access of Cancer Bioshield™ to treat Solid Tumor Lymphopenia

    We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.

    This wording observed 5 July 2025.

    archived page
  4. Seen January 2025 · 1 captureANKTIVA’s permanent J Code, J9028, is active for billing purposes effective Jan 1, 2025

    We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.

    This wording observed 8 January 2025.

    archived page
  5. Seen January 2024 · 1 captureOutsmart Your Disease ®

    ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.

    This wording observed 1 January 2024.

    archived page
  6. Seen July 2023 · 1 captureResearching Ways to Prevent Cancer

    ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.

    This wording observed 5 July 2023.

    archived page
  7. Seen July 2022 · 1 captureFinding Better Treatments for Bladder Cancer

    ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.

    This wording observed 4 July 2022.

    archived page
  8. Seen January 2022 · 1 captureOutsmart Your Disease ™

    ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.

    This wording observed 5 January 2022.

    archived page
  9. Seen July 2020 · 1 captureImmunityBio, Inc.

    This wording observed 11 July 2020.

    archived page

Cite this record

StartupHistory, “ImmunityBio” company record, https://startuphistory.org/c/immunitybio.com

Machine-readable: /c/immunitybio.com.json. How changes are found: method.